2013 Fiscal Year Final Research Report
The effect of NMO-IgG and complement against primary human astrocytes in culture.
Project/Area Number |
24890017
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Neurology
|
Research Institution | Tohoku University |
Principal Investigator |
|
Project Period (FY) |
2012-08-31 – 2014-03-31
|
Keywords | 視神経脊髄炎 / アストロサイト / 補体介在性障害 / 補体非介在性障害 |
Research Abstract |
Purified IgG derived from anti-Aquaporin 4(AQP4) antibody positive patients(NMO-IgG) itself caused AQP4 cluster on astrocytic membrane following endocytosis. NMO-IgG also caused reversible morphological changes like shrinking of foot processes and adhesion ability. NMO-IgG with human complements irreversibly damage the cells in a short time, suggesting a unique AQP4 antibody-mediated astrocytopathy in NMO. Complement is involved in the pathogenesis of NMO, and the worn-out of complement regulatory proteins like CD55 or CD59 on the membrane accelerate astrocytic cytotoxicity. The controlling of complement or complement regulatory proteins may be a new therapeutic target in NMO.
|
Research Products
(5 results)
-
-
-
[Presentation] A multicentric cross-sectional study of the usefulness of CSF-GFAP in the diagnosis and the prognosis of inflammatory demyelinating diseases2013
Author(s)
S. Nishiyama, T. Misu, Y. Simizu, K. Yokoyama, T. Kageyama, Y. Takai, R. Takano, T. Takahashi, J. Fujimori, S. Sato, I. Nakashima, Y. Itoyama, K. Fujihara, M. Aoki
Organizer
PACTRIMS 2013
Place of Presentation
京都
Year and Date
20131106-08
-
[Presentation] A multicentric cross-sectional study of the usefulness of CSF-GFAP in the diagnosis and the prognosis of inflammatory demyelinating diseases2013
Author(s)
S. Nishiyama, T. Misu, Y. Simizu, K. Yokoyama, T. Kageyama, Y. Takai, R. Takano, T. Takahashi, J. Fujimori, S. Sato, I. Nakashima, Y. Itoyama, K. Fujihara, M. Aoki
Organizer
29th ECTRIMS
Place of Presentation
デンマーク・コペンハーゲン
Year and Date
20131002-05
-